Rx/Reimbursement Adult Incontinence in Denmark

Value sales of RX/reimbursement adult incontinence grew in 2024 in Denmark, supported by the ageing population. It is estimated that around 80% of reimbursement recipients are aged 65 and older, a group that is expanding as life expectancy increases. The ageing population, coupled with rising obesity rates, underpins the recorded growth for RX/reimbursement adult incontinence in 2024, due to the strong link between older age, obesity, and incontinence.

Euromonitor International's Rx/Reimbursement adult incontinence in Denmark report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2029 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.